EPISODE · Dec 15, 2022 · 18 MIN
1733: Improving Combination Therapy with Navid Alipour
from LifeBlood · host LifeBlood
LifeBlood: We talked about improving combination therapy, detecting cancer quickly and efficiently, and removing any roadblocks to proactive medical care, with Navid Alipour, Founder and CEO of AI Med Global.Listen to learn about the future of personalized care!You can learn more about Navid at AIMedGlobal.com, Facebook, Twitter and LinkedIn. To give the gift of CureMatch, enter CureMatchPodcast at checkout. Thanks, as always for listening! If you got some value and enjoyed the show, please leave us a review here:https://ratethispodcast.com/lifebloodpodcastYou can learn more about us at LifeBlood.Live, Twitter, LinkedIn, Instagram, YouTube and Facebook or you’d like to be a guest on the show, contact us at [email protected]. Stay up to date by getting our monthly updates.Want to say “Thanks!” You can buy us a cup of coffee.https://www.buymeacoffee.com/lifeblood
What this episode covers
LifeBlood: We talked about improving combination therapy, detecting cancer quickly and efficiently, and removing any roadblocks to proactive medical care, with Navid Alipour, Founder and CEO of AI Med Global. Listen to learn about the future of personalized care! You can learn more about Navid at AIMedGlobal.com, Facebook, Twitter and LinkedIn. To give the gift of CureMatch, enter CureMatchPodcast at checkout. Thanks, as always for listening! If you got some value and enjoyed the show, please leave us a review here: https://ratethispodcast.com/lifebloodpodcast You can learn more about us at LifeBlood.Live, Twitter, LinkedIn, Instagram, YouTube and Facebook or you’d like to be a guest on the show, contact us at [email protected]. Stay up to date by getting our monthly updates. Want to say “Thanks!” You can buy us a cup of coffee. https://www.buymeacoffee.com/lifeblood
NOW PLAYING
1733: Improving Combination Therapy with Navid Alipour
No transcript for this episode yet
Similar Episodes
May 13, 2026 ·54m
May 6, 2026 ·69m
May 5, 2026 ·45m
Apr 22, 2026 ·58m